RevathiSuppiahMD

Summary

• Dr. Revathi Suppiah rejoined Cancer Treatment Centers of America® (CTCA) in September 2022 after an 18-month interlude conducting clinical research for a pharmaceutical company. Dr Suppiah, who served as Hematologist-Oncologist at CTCA® Chicago from September 2012 to October 2020, is excited to continue working with her multidisciplinary team to develop comprehensive, personalized care plans for her patients at CTCA Phoenix and the CTCA Outpatient Care Center in Scottsdale, Arizona. She returned to CTCA with extensive experience as a clinical researcher, including serving as principal investigator on multiple clinical trials. She has co-authored several publications in scientific journals and abstracts for national meetings and has written on topics such as metastatic gastrointestinal malignancies and the importance of liquid tumor biopsies. She has a particular interest in lung and gastrointestinal tract
  
  Dr. Suppiah came back to CTCA because she missed clinical medicine and working with patients. And she values the long-term physician-patient relationships.
  
  “I believe medical oncologists have a central role on a cancer patient’s multidisciplinary care team,” says Dr. Suppiah. “We are integral patient educators who can play an important role in helping patients make informed decisions, which requires us to have strong communication with our patients and other providers of the medical care team.”